title: International Conference on Harmonisation; Electronic   Transmission of Postmarket Individual Case Safety Reports for Drugs and Biologics, Excluding Vaccines; Availability of Food and Drug   Administration Regional Implementation Specifications for ICH E2B(R3)  Reporting to the Food and Drug Administration Adverse Event Reporting System. Notice of Availability.
abstract: The Food and Drug Administration (FDA) is announcing the availability of its FDA Adverse Event Reporting System (FAERS) Regional Implementation Specifications for the International Conference on Harmonisation (ICH) E2B(R3) Specification. FDA is making this technical specifications document available to assist interested parties in electronically submitting individual case safety reports (ICSRs) (and ICSR attachments) to the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER). This document, entitled "FDA Regional Implementation Specifications for ICH E2B(R3) Implementation: Postmarket Submission of Individual Case Safety Reports (ICSRs) for Drugs and Biologics, Excluding Vaccines" supplements the "E2B(R3) Electronic Transmission of Individual Case Safety Reports (ICSRs) Implementation Guide--Data Elements and Message Specification" final guidance for industry and describes FDA's technical approach for receiving ICSRs, for incorporating regionally controlled terminology, and for adding region-specific data elements when reporting to FAERS.
mesh_terms: D001688:Biological Products; D003226:Congresses as Topic; D017277:Drug Approval; D001330:Electronic Data Processing / Q000592:standards*; D006801:Humans; D007391:International Cooperation; D017387:Investigational New Drug Application; D008499:Medical Records; D055553:Prescription Drugs; D011358:Product Surveillance, Postmarketing; D012449:Safety; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D001688:Biological Products; D055553:Prescription Drugs